Letter

Transdermal glyceryl trinitrate for dysmenorrhoea

BMJ 1996; 313 doi: 10.1136/bmj.313.7053.364a (Published 10 August 1996)
Cite this as: BMJ 1996;313:364.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Confidence intervals for glyceryl trinitrate do not suggest a significant effect

  1. A Li Wan Po,
  2. R W Stones
  1. Professor of clinical pharmaceutics Centre for Evidence-Based Pharmacotherapy, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD
  2. Professor of clinical pharmaceutics Centre for Evidence-Based Pharmacotherapy, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD

    EDITOR,—Effective treatments for dysmenorrhoea (combined oral contraceptives and non-steroidal anti-inflammatory drugs) are available, but, as R Pittrof and colleagues state, contraindications to non-steroidal anti-inflammatory drugs make them unsuitable in some patients.1 The authors suggest, on the basis of a small clinical trial, that transdermal glyceryl trinitrate is a …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular